← Back to search

NEKTAR THERAPEUTICS

NKTR · NASDAQ

Pharmaceutical Preparation Manufacturing

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India.

ESG Scores

Overall ESG
3.0
Environmental
2.4
Social
2.6
Governance
4.6

Gender Diversity

Female Directors0.375%
Female Executives0.17094017094017094%
CEO GenderMale

Market Data

Price$84.86+0.87 (+1.04%)
Market Cap$2.43B
P/E Ratio
EPS$—
52W High$86.95
52W Low$7.99
Beta1.22